← Back to Search

Ultrasound Scanner

Magnetic Resonance Imaging (MRI) for Bone Infections

N/A
Waitlist Available
Led By Oscar M Alvarez, PhD
Research Sponsored by Calvary Hospital, Bronx, NY
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to establish the sensitivity of HRUS as compared to MRI for the diagnosis of osteomyelitis in chronic wound patients; and to determine the specificity of HRUS as compared to pathologic and microbiologic studies of bone biopsy tissues.

Eligible Conditions
  • Bone Infections

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Magnetic Resonance Imaging (MRI)Active Control1 Intervention
Magnetic Resonance Imaging (MRI)
Group II: High Resolution UltrasoundActive Control1 Intervention
High Resolution Ultrasonography (HRUS) with a Hitachi-Aloka Noblus Scanner

Find a Location

Who is running the clinical trial?

Calvary Hospital, Bronx, NYLead Sponsor
12 Previous Clinical Trials
1,423 Total Patients Enrolled
Martin Wendelken, DPM, RNStudy DirectorStaff Podiatrist, Wound Care Center, Calvary Hospital, Bronx, NY
Oscar M Alvarez, PhDPrincipal InvestigatorDirector, Wound Care Center, Calvary Hospital
5 Previous Clinical Trials
174 Total Patients Enrolled
~9 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top